Study guide

5.2 Vesiculobullous, Ulcerative & Autoimmune Mucosal Conditions

Licentiate in Dental Surgery LDS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinically Applied Human Disease & General Medicine

1.1 Cardiovascular, Respiratory & Endocrine Disorders in Dental Practice 1.2 Haematology, Hepatic & Renal Disease & Bleeding Disorders 1.3 Medical Emergencies in the Dental Chair & Management

2 Chapter 2: Special Medical Considerations & Compromised Patients

2.1 Dental Management of Medically Compromised Patients 2.2 Immunocompromised, Transplants & Oncology Patients 2.3 Pregnancy, Ageing & Special Needs Patients in Dentistry

3 Chapter 3: Oral Biology, Dental Anatomy & Embryology

3.1 Face, Palate & Tooth Development & Embryology 3.2 Tooth Morphology, FDI Numbering & Eruption Sequences 3.3 Structure & Function of Dental Hard Tissues 3.4 Pulp-Dentine Complex, Periodontium & Salivary Gland Physiology

4 Chapter 4: Oral & Maxillofacial Pathology

4.1 Caries & Periodontal Histopathology & Pathogenesis 4.2 Odontogenic Cysts, Tumours & Developmental Anomalies 4.3 Bone Pathology, Jaw Disorders & Salivary Gland Diseases

5 Chapter 5: Oral Medicine & Mucosal Diseases

5.1 Potentially Malignant Disorders & Oral Squamous Cell Carcinoma 5.2 Vesiculobullous, Ulcerative & Autoimmune Mucosal Conditions 5.3 Oral Infections & Orofacial Pain Management

6 Chapter 6: Oral Microbiology & Infection Control

6.1 Oral Microflora, Dental Plaque Biofilm & Microbial Ecology 6.2 Cariogenic & Periodontal Pathogens & Systemic Links 6.3 Cross-Infection Control, Sterilisation, Decontamination & HTM 01-05

7 Chapter 7: Pharmacology & Therapeutics

7.1 Local Anaesthetics, Dosing, Vasoconstrictors & Toxicity 7.2 Analgesics, NSAIDs, Opioids & Conscious Sedation Pharmacology 7.3 Antimicrobial Prescribing, BNF/DPF Guidance & Stewardship 7.4 Drugs Affecting Haemostasis, Bone (MRONJ) & Drug Interactions

8 Chapter 8: Dental Materials Science

8.1 Amalgam, Composite Resins, Bonding Agents & Adhesion 8.2 Glass-Ionomer Cements, Resin-Modified GICs & Luting Cements 8.3 Impression Materials, Gypsum Products & Dental Waxes 8.4 Dental Ceramics, Restorative Alloys & Material Biocompatibility

9 Chapter 9: Principles of Clinical Dentistry

9.1 Operative Dentistry, Endodontics & Periodontology Principles 9.2 Fixed & Removable Prosthodontics & Occlusion 9.3 Paediatric Dentistry, Orthodontics & Oral Surgery Essentials 9.4 Dental Radiography, Image Interpretation & Radiation Protection (IRR17/IRMER17)

10 Chapter 10: Law, Ethics, Governance & Health & Safety

10.1 GDC Standards for the Dental Team & Professionalism 10.2 Valid Consent, Capacity (MCA), Confidentiality & Safeguarding 10.3 Health & Safety, Clinical Governance, Audit & Risk Management

5.2 Vesiculobullous, Ulcerative & Autoimmune Mucosal Conditions

Key Takeaways Explain This Topic AI

Pemphigus vulgaris is characterized by intraepithelial suprabasal acantholysis, positive Nikolsky sign, autoantibodies against Desmoglein 3, and a net-like/chicken-wire intercellular IgG/C3 pattern on direct immunofluorescence (DIF).

Mucous membrane pemphigoid features subepithelial splitting, negative Nikolsky sign, autoantibodies against BP180 in hemidesmosomes, continuous linear IgG/C3 at the basement membrane zone (BMZ) on DIF, and a high risk of scarring ocular complications.

Oral Lichen Planus (OLP) demonstrates saw-tooth rete pegs, basal cell liquefaction degeneration, and a band-like T-lymphocytic infiltrate; management ranges from observation for reticular forms to potent topical corticosteroids (clobetasol) for erosive forms.

Recurrent Aphthous Stomatitis (RAS) is categorized into minor (<10mm, heals without scarring), major (>10mm, deep, heals with scarring), and herpetiform (clusters of pinpoint ulcers); systemic screening for iron, B12, folate deficiency, and Coeliac disease is mandatory.

Erythema Multiforme is an acute immune-complex hypersensitivity reaction triggered by HSV infections or drugs, characterized by crusted hemorrhagic lips, painful oral erosions, and cutaneous target lesions.

Last updated: July 2026

5.2 Vesiculobullous, Ulcerative & Autoimmune Mucosal Conditions

Quick Reference: Autoimmune vesiculobullous conditions present severe diagnostic challenges in oral medicine. Differentiating Pemphigus Vulgaris (intraepithelial split) from Mucous Membrane Pemphigoid (subepithelial split) relies on precise biopsy techniques and Direct Immunofluorescence (DIF) mapping of target autoantigens.

Autoimmune Vesiculobullous Disorders

Autoimmune vesiculobullous diseases are caused by pathogenic autoantibodies directed against structural adhesion proteins of the oral mucosa. The target autoantigens dictate whether the histological cleavage occurs within the epithelium ( acantholysis ) or beneath the epithelium at the basement membrane zone .

Comparative Diagnostic Matrix: Pemphigus Vulgaris vs. Mucous Membrane Pemphigoid

Feature Pemphigus Vulgaris (PV) Mucous Membrane Pemphigoid (MMP)

Primary Autoantigen Target Desmoglein 3 (transmembrane cadherin in desmosomes); Dsg1 in cutaneous disease BP180 (Type XVII collagen), BP230, or Laminin 332 in hemidesmosomes

Histopathological Split Level Intraepithelial acantholysis (suprabasal clefting above basal cell layer) Subepithelial split (entire epithelium detaches cleanly from lamina propria)

Nikolsky Sign Positive (stroking normal mucosa induces blister formation or sloughing) Negative or weakly positive

Clinical Bullae Behavior Flaccid, extremely fragile, rupture rapidly leaving widespread painful sloughing erosions Tense, persistent bullae that may remain intact for days before rupturing

Direct Immunofluorescence (DIF) Net-like / Chicken-wire intercellular deposition of IgG and C3 throughout spinous layer Continuous linear band of IgG and C3 deposition along the Basement Membrane Zone (BMZ)

Indirect Immunofluorescence (IIF) Positive in >80-90% of active cases (circulating anti-Dsg3 antibody titers reflect disease activity) Frequently negative or weak low-titer circulating antibodies

Oral Site Distribution Soft palate, buccal mucosa, labial mucosa, gingiva; oral lesions precede skin lesions in 50-70% Predominantly desquamative gingivitis , hard palate, buccal mucosa

Extraoral Complications Cutaneous involvement, esophageal/nasal sloughing, severe dehydration, sepsis Ocular scarring (symblepharon, ankyloblepharon, trichiasis) causing irreversible blindness

Clinical Pearl: Any patient diagnosed with Mucous Membrane Pemphigoid requires an urgent referral to an Ophthalmologist , regardless of whether ocular symptoms are reported, to screen for subclinical conjunctival scarring.

Oral Lichen Planus (OLP) & Lichenoid Reactions

Oral Lichen Planus (OLP) is a chronic cell-mediated autoimmune disease wherein CD8+ T-lymphocytes induce apoptosis of basal keratinocytes. It affects approximately 1-2% of the UK population, predominantly middle-aged females.

Clinical Subtypes of Oral Lichen Planus

Reticular Lichen Planus: Most common presentation. Features non-wipeable, asymptomatic fine white lacelike striae known as Wickham striae , typically presenting bilaterally and symmetrically on the posterior buccal mucosa.

Erosive / Ulcerative Lichen Planus: Painful central irregular ulcerations surrounded by erythematous mucosa and radiating Wickham striae. High symptomatic burden.

Atrophic / Desquamative Lichen Planus: Presents as fiery red, shiny desquamative gingivitis affecting attached gingiva.

Plaque-like Lichen Planus: Homogeneous white, smooth or slightly rough fixed plaques resembling leukoplakia, often on the dorsum of the tongue.

Bullous Lichen Planus: Rare variant where subepithelial fluid accumulation leads to short-lived mucosal bullae.

Histopathological Triad of Lichen Planus

Hyperkeratosis / Parakeratosis with characteristic saw-tooth rete pegs (irregular pointed elongation of epithelial ridges).

Liquefaction degeneration of the basal layer: Apoptosis and hydropic degeneration of basal keratinocytes forming round colloid/apoptotic bodies ( Civatte bodies ).

Band-like (lichenoid) lymphocytic infiltrate: Dense band of T-lymphocytes restricted strictly to the subepithelial juxta-epithelial zone of the lamina propria.

Oral Lichenoid Contact Reactions

Lichenoid reactions clinically and histopathologically mimic OLP but are unilateral and associated with an identifiable trigger:

Contact Hypersensitivity: Direct contact with dental amalgam restorations (mercury resin release) or composite components. Resolves following replacement of the adjacent restoration.

Drug-Induced Lichenoid Eruption: Triggered by systemic medications including ACE inhibitors (captopril, enalapril), NSAIDs, beta-blockers, thiazide diuretics, and oral hypoglycemics.

Recurrent Aphthous Stomatitis (RAS)

Recurrent Aphthous Stomatitis (RAS) is the most prevalent mucosal disease worldwide, affecting up to 20% of the population. It presents as recurring, self-limiting, painful ulcerations confined almost exclusively to non-keratinised mucosal surfaces (buccal mucosa, labial mucosa, floor of mouth, ventral tongue).

Classification of Aphthous Ulceration

  • Feature Minor Aphthae Major Aphthae (Sutton Disease) Herpetiform Aphthae
  • Proportion of Cases 80-85% 10-15% 5-10%
  • Ulcer Size Small, <10 mm (typically 2-8 mm) Large, >10 mm (often 1-3 cm) Multiple pinpoint, 1-3 mm ulcers
  • Number of Ulcers 1 to 5 ulcers per crop 1 to 3 deep ulcers per crop Dozens (10 to 100) coalescing crops

Mucosal Distribution Non-keratinised mucosa only Non-keratinised AND keratinised mucosa (soft palate, pharynx) Non-keratinised mucosal surfaces

  • Healing Duration Heals within 7-14 days Takes 3 to 6 weeks or months Heals within 10-14 days
  • Scarring Heals without scarring Heals with significant fibrous scarring Heals without scarring
  • Underlying Systemic Etiologies & Workup

Primary care dentists investigating recurrent or severe aphthous-like ulceration must arrange systemic blood screening:

Hematinic Deficiencies: Iron deficiency anemia (low serum ferritin), Vitamin B12 deficiency, or folate deficiency.

Gastrointestinal Disease: Coeliac Disease (screened via serum anti-tissue transglutaminase anti-tTG antibodies), Crohn's Disease, Ulcerative Colitis.

Behçet Disease: Triad of recurrent major aphthous ulceration, recurrent genital ulceration, and anterior/posterior uveitis (HLA-B51 association).

Erythema Multiforme (EM) & Hypersensitivity Reactions

Erythema Multiforme (EM) is an acute, self-limiting Type IV hypersensitivity reaction involving the skin and mucous membranes. It is characteristically triggered by precursor infections, predominantly Herpes Simplex Virus (HSV-1/2) (in >70% of cases) or Mycoplasma pneumoniae , and less commonly by drugs (sulfonamides, anticonvulsants, NSAIDs).

Clinical Features

Crusted Hemorrhagic Lips: Extensive dark blood crusting and swelling of the vermilion border of the lips is pathognomonic.

Widespread Oral Ulceration: Irregular, painful bullae and erosions across non-keratinised and keratinised surfaces.

Cutaneous Target (Iris) Lesions: Concentric erythematous rings with a central purpuric or vesicular zone located symmetrically on the extensor surfaces of limbs, palms, and soles.

Spectrum of Disease Severity

EM Minor: Mucosal ulceration with limited cutaneous target lesions; no systemic toxicity.

EM Major: Severe mucosal involvement (at least 2 mucosal sites: oral, ocular, genital) alongside widespread cutaneous target lesions.

Stevens-Johnson Syndrome (SJS): Severe drug-induced mucocutaneous detachment involving <10% of total body surface area (BSA) with high fever and systemic collapse.

Toxic Epidermal Necrolysis (TEN): Life-threatening dermatological emergency featuring >30% BSA full-thickness epidermal necrolysis. Requires urgent transfer to a regional burn unit.